<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Pulmonary-Allergy Drugs Advisory Committee; Cancellation</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Pulmonary-Allergy Drugs Advisory Committee; Cancellation</h1>
    <p class="timestamp">Published: 2019-04-02 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The meeting of the Pulmonary-Allergy Drugs Advisory Committee scheduled for March 27, 2019, has been cancelled. This meeting was announced in the Federal Register of January 31, 2019. This meeting has been cancelled due to new information regarding the application. The Agency intends to continue evaluating the application and, as needed, will announce future meeting dates in the Federal Register.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2019-06389</p>
    <p><strong>Publication Date:</strong> 2019-04-02</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2019/04/02/2019-06389/pulmonary-allergy-drugs-advisory-committee-cancellation">https://www.federalregister.gov/documents/2019/04/02/2019-06389/pulmonary-allergy-drugs-advisory-committee-cancellation</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2019-06389</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
